SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-000847
Filing Date
2022-01-28
Accepted
2022-01-28 16:30:14
Documents
1
Period of Report
2022-01-26

Document Format Files

Seq Description Document Type Size
1 form4-01282022_040102.html 4  
1 form4-01282022_040102.xml 4 4178
  Complete submission text file 0001415889-22-000847.txt   5616
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Laccona Nicholas (Reporting) CIK: 0001886497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 22569280